Opinion|Videos|September 25, 2024
Guiding Patients Through Third-Line mCRC Therapy Decisions
Medical experts discuss how to frame the conversation with patients about third-line metastatic colorectal cancer treatment selection, balancing efficacy, safety, and overall prognosis.
Advertisement
Episodes in this series
Video content above is prompted by the following:
When discussing treatment selection in the third-line setting for metastatic colorectal cancer, how do you frame this conversation with patients, balancing efficacy, safety, and overall prognosis?
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes
2
Unvaccinated COVID-19 Infection Tied to Higher Myocarditis Risk
3
DOJ Abandons Olmstead Defense as Texas v Kennedy Advances
4
MRI Shows Hypothalamic Atrophy in Narcolepsy Type 1, Sparing Subregion
5